Liminal Biosciences SG&A Expense (Quarterly)

Liminal Biosciences Inc (LMNL)

6.94 -0.01 (-0.14%) USD | NASDAQ | May 26, 16:00

6.58 -0.36 (-5.19%) After-Hours: 20:00

SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 1997. Upgrade now.

Date	Value
March 31, 2023	2.630M
December 31, 2022	2.900M
September 30, 2022	3.359M
June 30, 2022	3.637M
March 31, 2022	3.708M
December 31, 2021	4.617M
September 30, 2021	7.479M
June 30, 2021	6.963M
March 31, 2021	6.42M
December 31, 2020	5.759M
September 30, 2020	5.653M
June 30, 2020	6.134M
March 31, 2020	7.944M
December 31, 2019	2.012M
September 30, 2019	7.467M
June 30, 2019	13.48M
March 31, 2019	5.334M
December 31, 2018	6.488M
September 30, 2018	4.759M
June 30, 2018	5.381M
March 31, 2018	6.099M
December 31, 2017	5.427M
September 30, 2017	6.105M
June 30, 2017	5.992M
March 31, 2017	5.245M

Date	Value
December 31, 2016	8.981M
September 30, 2016	4.964M
June 30, 2016	4.023M
March 31, 2016	3.516M
December 31, 2015	3.991M
September 30, 2015	3.156M
June 30, 2015	3.065M
March 31, 2015	2.703M
December 31, 2014	3.382M
September 30, 2014	2.929M
June 30, 2014	2.468M
March 31, 2014	1.930M
December 31, 2013	3.584M
September 30, 2013	1.907M
June 30, 2013	1.271M
March 31, 2013	1.486M
December 31, 2012	1.938M
September 30, 2012	1.25M
June 30, 2012	1.254M
March 31, 2012	1.395M
December 31, 2011	1.366M
September 30, 2011	1.453M
June 30, 2011	1.440M
March 31, 2011	1.596M
December 31, 2010	1.322M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

2.012M

Minimum

Dec 2019

13.48M

Maximum

Jun 2019

5.606M

Average

5.517M

Median

SG&A Expense (Quarterly) Benchmarks